-
Mashup Score: 2Report: Cancer Community Making Progress in Achieving Equity in Care - 7 month(s) ago
A new report in JCO Oncology Practice outlines progress made towards reducing cancer disparities among sexual and gender minorities and achieving equity across patient education and support,
Source: old-prod.asco.orgCategories: Latest Headlines, Partners & KOLsTweet-
New @ASCO report published in #JCOOP outlines progress made towards reducing cancer disparities among sexual & gender minorities and achieving equity across pt education/support, workforce development/diversity, quality improvement, policy, and research: https://t.co/HjEYIBY6sA https://t.co/uRKkq5g2b4
-
-
Mashup Score: 8Gastrointestinal Cancer - 7 month(s) ago
Gastrointestinal Cancer
Source: old-prod.asco.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 1
AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Evaluating Oncology Clinical Pathways: What Bar Are We Aiming for? - 8 month(s) ago
Oncology clinical pathways may result in cost savings, but we need more understanding about patient outcomes and reasons for nonadherence.
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
AUTHOR’S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST Integrating Palliative Care into Oncology: Location, Location, Location? The following represents disclosure information provi ded by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Preventing Future Harm: Identifying the Drivers of an Unsafe Discharge to Improve Safety on an Inpatient Oncology Service - 9 month(s) ago
Cancer Morbidity, Mortality, and Improvement Rounds is a series of articles intended to explore the unique safety risks experienced by oncology patients through the lens of quality improvement, systems and human factors engineering, and cognitive psychology. For purposes of clarity, each case focuses on a single theme, although, as is true for all medical incidents, there are almost always multiple, overlapping, contributing factors. The quality improvement paradigm used here, which focuses on root cause analyses and opportunities to improve care delivery systems, was previously outlined in this journal. This article describes the care of a young patient with aggressive breast cancer, declining performance status, and multiple hospital admissions who died shortly after being discharged home without essential medications or an adequate plan for follow-up. The patient’s death due to her malignancy was unavoidable, but she had inadequate resources before her death, leading to avoidable su
Source: ascopubs.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Optimizing and Refining Immunotherapy in Breast Cancer - 1 year(s) ago
Despite a rocky start in breast cancer, immune checkpoint inhibitors (ICIs) have now made their way into clinical practice.1 As noted in the review article accompanying this commentary by Jacob et al2 titled Role of Immunotherapy in Breast Cancer, the journey in developing immunotherapy in breast cancer has been challenging. Indeed, we have observed mostly low response rates to single-agent ICIs,…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0JCO Oncology Practice: Vol 19, No 1 - 1 year(s) ago
FROM THE EDITOR’S DESKSPECIAL SERIES: TEAMS IN CANCER CAREEDITORIALSCLINICAL REVIEWSCommentariesSPECIAL SERIES: TEAMS IN CANCER CAREQUALITY IN ACTIONFocus on QualitySPECIAL SERIES: TEAMS IN CANCER CAREMORBIDITY, MORTALITY AND IMPROVEMENT ROUNDSGUIDELINE SUMMARIESFocus on QualitySPECIAL SERIES: TEAMS IN CANCER CAREORIGINAL CONTRIBUTIONS
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
PURPOSE: Cancer trial participants do not reflect the racial and ethnic diversity in the population of people with cancer in the United States. As a result of multiple system-, patient-, and provider-level factors, including implicit bias, cancer clinical trials are not consistently offered to all potentially eligible patients. MATERIALS AND METHODS: ASCO and ACCC evaluated the utility (pre- and…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Clinical trial participants do not reflect the racial and ethnic diversity of people with cancer. ASCO and the Association of Community Cancer Centers collaborated on a quality improvement study to enhance racial and ethnic equity, diversity, and inclusion (EDI) in cancer clinical trials. The groups conducted a pilot study to examine the feasibility, utility, and face validity of a two-part…
Source: JCO Oncology PracticeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Check out a new report in @JCOOP_ASCO highlighting progress made towards reducing cancer disparities and achieving equity among sexual & gender minority communities: https://t.co/oBtxGO96NH @drdonsdizon @chunkitfung @LolaFashoyinAje @JeamesSailor @J_K_Merrill #SGMhealth https://t.co/PGB83a29z4